What You Should Know:
– Prominence Advisors, a leader in healthcare data enablement, has announced its acquisition of Tegra Analytics, a life sciences analytics consultancy. The acquisition extends Prominence’s data enablement platform into the life…
Continue Reading
What You Should Know:
– ArcaScience, a Paris, France-based AI Healthtech startup, has announced a $7M seed funding round led by The Moon Venture, with participation from Pléiade Venture, Plug&Play Ventures, Bpifrance, and AKKA Technologies….
Continue Reading
What You Should Know:
– Medable, a technology provider for clinical development, has launched Agent Studio, which it calls the industry’s first agentic AI platform purpose-built for life sciences.
– Agent Studio is a no-code agent-builder…
Continue Reading
We're excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Miha Štajdohar, Co-Founder and CTO at Genialis. Genialis develops and markets an…
Continue Reading
What You Should Know:
– Alphabet’s Verily announced in an internal memo that is has closed its medical device division and laid off staff. The exact number of employees affected was not revealed.
– According to…
Continue Reading
What You Should Know:
– Veeva Systems has announced a new collaboration with Amgen, a global leader in biotechnology, to advance clinical trial innovation.
– Amgen will use the Veeva Clinical Platform to find and implement…
Continue Reading
What You Should Know:
– EVERSANA and Waltz Health have announced a merger valued at $6B to form a unified healthcare platform that will redefine pharmaceutical commercialization and patient access.
– The merger combines Waltz Health’s…
Continue Reading
What You Should Know:
– Eli Lilly and Company has announced positive topline results from its Phase 3 ATTAIN-2 trial, which evaluated orforglipron, an investigational oral GLP-1 receptor agonist, in adults with obesity or overweight…
Continue Reading
What You Should Know:
– AbbVie and Gilgamesh Pharmaceuticals Inc. have announced a definitive agreement for AbbVie to acquire Gilgamesh’s lead investigational candidate, bretisilocin, which is in clinical development for the treatment of patients with…
Continue Reading
We're excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. I am once again taking over for Danny to sit down with Andrea Douglas, Director Business…
Continue Reading
